17-0700-01	2',5' ADP-SEPHAROSE 4B   5 G
17-0756-01	GLUTATHIONE SEPHAROSE 4B 10 M
17-0756-04	GLUTATHIONE SEPHAROSE 4B, 300
17-0756-05	GLUTATHIONE SEPHAROSE 4B, 100M
17-0780-01	PROTEIN A-SEPHAROSE CL-4B 1.5G
17-0820-01	CNBR ACTIVATED SEPHAROSE 6MB
17-0885-01	GAMMABIND G SEPHAROSE, 5 ML
17-0885-02	GAMMABIND G SEPHAROSE, 25 ML
17-0885-04	GAMMABIND G SEPHAROSE, 250 ML
17-0886-01	GAMMABIND PLUS SEPHAROSE, 5 ML
17-0886-02	GAMMABIND PLUS SEPHAROSE, 25 M
17-0886-04	GAMMABIND PLUS SEPHAROSE, 500
17-0906-01	NHS ACT SEPHAROSE 4 FF 25 ML
17-0920-06	IMAC SEPHAROSE HP, 25 ML
17-0920-07	IMAC SEPHAROSE HP, 100 ML
17-0921-07	IMAC SEPHAROSE 6 FF, 25 ML
17-0921-08	IMAC SEPHAROSE 6 FF, 100 ML
17-0948-01	BLUE SEPHAROSE 6 FAST FLOW, 50
17-0956-01	GELATIN-SEPHAROSE 4B, 25 ML
17-0963-02	PROTEIN A SEPHAROSE CL-4B 500M

2'5' ADP Sepharose™ 4B

• 2'5' ADP is an NADP structural analog immobilized on Sepharose™ 4B. It binds and immobilizes enzymes requiring this cofactor

2'5' ADP Sepharose™ 4B

Technical Information

TECHNICAL SPECIFICATIONS
Ligand coupling method	Cyanogen bromide activation
Ligand concentration	» 2 μmol ligand/ml medium
Matrix	Cross-linked agarose, 4%
Binding capacity	» 0.4 mg G6PDH/ml medium
Storage temperature	4°C to 8°C

http://www.gelifesciences.com/aptrix/upp01077.nsf/Content/Products?OpenDocument&moduleid=14124